Lucent Industries Limited has entered into a partnership agreement with Clusterdev Technologies Private Limited, which provides ...

Nerve or neuropathic pain has long been a tricky condition to treat effectively. However, a new study has comprehensively ...

By Julia Landwehr and Nick Blackmer Nearly 40 different kinds of common generic medications are being recalled, according to ...

Nearly 40 generic medications targeting heart and brain illnesses produced by Glenmark Pharmaceuticals have been recalled by the Food and Drug Administration ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get the AARP Now app. New and improved, it’s the app that makes ...

500-count bottles Lacosamide tablets 200 mg, 60-count bottle Frovatriptan succinate tablets 2.5 mg, 9-count bottle Rufinamide tablets 200 mg, 120-count bottle Nitroglycerin sublingual tablets 0.4 ...

Their presence may explain why EFAPG do not always respond to sodium channel blockers (eg, lacosamide). Further, several current analgesics (clonidine, dexmedetomidine, ketamine and systemic lidocaine ...

The company is also recalling other products such as Voriconazole Tablets, Lacosamide Tablets, Frovatriptan Succinate Tablets, and Rufinamide Tablets. This Class II recall was initiated on March 13, ...

ALSO READ: Glenmark Pharma share rises 2% on securing USFDA nod; key details here It is also recalling products like Voriconazole Tablets, Lacosamide Tablets, Frovatriptan Succinate Tablets and ...

It is also recalling products like Voriconazole Tablets, Lacosamide Tablets, Frovatriptan Succinate Tablets and Rufinamide Tablets. The company initiated the Class II recall on March 13 this year. As ...

It is also recalling products like Voriconazole Tablets, Lacosamide Tablets, Frovatriptan Succinate Tablets and Rufinamide Tablets. The company initiated the Class II recall on March 13 this year. As ...

It is also recalling products like Voriconazole Tablets, Lacosamide Tablets, Frovatriptan Succinate Tablets and Rufinamide Tablets. The company initiated the Class II recall on March 13 this year.